PuraPharm Corp. Ltd. (HK:1498)
:1498
Want to see HK:1498 full AI Analyst Report?
Total Valuation
PuraPharm Corp. Ltd. has a market cap or net worth of HK$160.48M. The enterprise value is HK$455.54M.
Market CapHK$160.48M
Enterprise ValueHK$455.54M
Share Statistics
PuraPharm Corp. Ltd. has 535,897,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding535,897,640
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PuraPharm Corp. Ltd.’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -6.02%.
Return on Equity (ROE)-0.27
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-6.02%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee701.70K
Profits Per Employee-71.84K
Employee Count479
Asset Turnover0.48
Inventory Turnover1.57
Valuation Ratios
The current PE Ratio of PuraPharm Corp. Ltd. is ―. PuraPharm Corp. Ltd.’s PEG ratio is 0.68.
PE Ratio―
PS Ratio0.44
PB Ratio1.14
Price to Fair Value1.14
Price to FCF5.79
Price to Operating Cash Flow7.41
PEG Ratio0.68
Income Statement
In the last 12 months, PuraPharm Corp. Ltd. had revenue of 336.11M and earned -35.22M in profits. Earnings per share was -0.08.
Revenue336.11M
Gross Profit180.16M
Operating Income-29.98M
Pretax Income-34.41M
Net Income-35.22M
EBITDA6.23M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was 17.92M and capital expenditures -284.00K, giving a free cash flow of 17.64M billion.
Operating Cash Flow17.92M
Free Cash Flow17.64M
Free Cash Flow per Share0.03
Dividends & Yields
PuraPharm Corp. Ltd. pays an annual dividend of HK$0.019, resulting in a dividend yield of ―
Dividend Per ShareHK$0.019
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change-41.18%
50-Day Moving Average0.31
200-Day Moving Average0.38
Relative Strength Index (RSI)45.55
Average Volume (3m)128.80K
Important Dates
PuraPharm Corp. Ltd. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateMar 25, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
PuraPharm Corp. Ltd. as a current ratio of 0.47, with Debt / Equity ratio of 269.11%
Current Ratio0.47
Quick Ratio0.27
Debt to Market Cap2.18
Net Debt to EBITDA52.98
Interest Coverage Ratio-1.45
Taxes
In the past 12 months, PuraPharm Corp. Ltd. has paid 813.00K in taxes.
Income Tax813.00K
Effective Tax Rate-0.02
Enterprise Valuation
PuraPharm Corp. Ltd. EV to EBITDA ratio is 76.85, with an EV/FCF ratio of 18.63.
EV to Sales1.42
EV to EBITDA76.85
EV to Free Cash Flow18.63
EV to Operating Cash Flow16.78
Balance Sheet
PuraPharm Corp. Ltd. has HK$21.18M in cash and marketable securities with HK$351.14M in debt, giving a net cash position of -HK$329.97M billion.
Cash & Marketable SecuritiesHK$21.18M
Total DebtHK$351.14M
Net Cash-HK$329.97M
Net Cash Per Share-HK$0.62
Tangible Book Value Per ShareHK$0.12
Margins
Gross margin is 53.60%, with operating margin of -8.92%, and net profit margin of -10.48%.
Gross Margin53.60%
Operating Margin-8.92%
Pretax Margin-10.24%
Net Profit Margin-10.48%
EBITDA Margin1.85%
EBIT Margin-4.83%
Analyst Forecast
The average price target for PuraPharm Corp. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-12.03%
EPS Growth Forecast6.24%